
Optional LGBTQ suicide prevention lifeline service ends
July 19 (UPI) -- The National Suicide Prevention Lifeline ceased its optional service for LGBTQ callers on Thursday after the Trump administration in June ordered it to end.
Callers can dial 988 to reach the national Suicide and Crisis Lifeline, which became active three years ago, but there is no option for LGBTQ callers, many of whom are young.
"This is a tragic moment," said Mark Henson, vice president of government affairs and advocacy for The Trevor Project.
"Many LGBTQ youth who use these services didn't know they existed until they called 988 and found out there is someone on the other end of the line that knows what they've gone through and cares deeply for them," Henson said.
The non-profit Trevor Project has operated the specialized LGBTQ suicide lifeline since 2022, but the "press 3 option" for LGBTQ callers no longer is available.
Although the option is gone, LGBTQ callers will be helped, but they won't be directed to those who might specialize in assisting those who identify as LGBTQ.
"Everyone who contacts the 988 Lifeline will continue to receive access to skilled, caring, culturally competent crisis counselors who can help with suicidal, substance misuse, mental health crises or any other kind of emotional distress," officials for the federal Substance Abuse and Mental Health Services Administration said.
SAMHSA is the federal agency tasked with managing the 988 suicide lifeline after President Donald Trump signed enabling legislation during his first term in office.
Congress had allocated $33 million for the LGBTQ lifeline for 2025, but those funds have been spent, according to SAMHSA.
Instead of seeking more funds, the Trump administration ended the option.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Hill
6 hours ago
- The Hill
We can't win the fight to end HIV if we cut funding and access to medication
The fight to end HIV in our lifetimes just received a game-changing innovation. In June, the FDA approved Yeztugo (lenacapavir), a groundbreaking HIV prevention treatment that requires just two injections per year — and scored 99 percent effectiveness in trials. This monumental scientific breakthrough is poised to transform the lives of people who have found it hard to keep up with daily oral pre-exposure prophylaxis, providing an option that fits better into their everyday lives. But as exciting as this development is, it could be undermined by the Trump administration's proposal to cut nearly $1 billion from federal HIV prevention programs. Innovations like lenacapavir could be a key tool to ending the epidemic, but only if we have the resources and policy to deliver it directly to those who need them most. Although lenacapavir's efficacy is groundbreaking, access remains another story. With a price tag hovering around $28,000 a year, this medication risks being out of reach for the very communities who need it most. We're still waiting to see how programs managed by Gilead Sciences, which developed the treatments, and the broader insurance markets will step up. And it's not just the cost of the drug itself. It's the labs, the provider visits, the follow-ups — each one a potential roadblock for someone trying to stay safe. Federal leadership is essential to ensuring this new HIV prevention tool reaches the communities who need it most. This includes updating clinical guidelines, funding support services and supporting the infrastructure that makes access possible. Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving innovations at risk. The administration's attacks on HIV prevention, including its proposals to eliminate the Centers for Disease Control and Prevention's HIV budget and efforts to dismantle public health systems, threaten progress. The Republican budget reconciliation bill that President Trump signed over the July 4 weekend includes deep cuts to Medicaid — the largest payer for HIV care in the U.S. Without strong federal investment and coordination, expanding access to new tools and ending the HIV epidemic is at serious risk. Despite the real strides we have made in HIV prevention, those of us in the lesbian, gay, and transgender community — especially non-white Southerners in rural areas or navigating poverty — know that not every prevention strategy reaches us, works for us, or is built with us in mind. Our realities demand options that reflect the full truth of who we are and how we live. Lenacapavir offers real, powerful hope, but let's be clear: Science alone won't save us. What will make the difference is equitable and intentional policies that center our communities and a public health infrastructure that doesn't leave us behind. These numbers don't shift on their own. Yes, we have made progress over time. But the hard truth is that Black Americans still account for 43 percent of all new HIV diagnoses in the U.S., despite being just 13 percent of the population. The data is even more stark for Black transgender women: 44 percent are living with HIV, and their lifetime risk remains unacceptably high. And we cannot ignore the geography of this epidemic. The South accounts for 52 percent of all new HIV diagnoses in the U.S. That's not a coincidence — it is the result of systemic failures: limited access to healthcare, persistent stigma, lack of comprehensive sex education and the absence of strong non-discrimination protections. These barriers don't just prevent care — they trap people in cycles where prevention tools are out of reach. Among gay and bisexual Black men, the risk of contracting HIV is still 50 percent over a lifetime. Prevention tools like pre-exposure prophylaxis and lenacapavir hold promise, but they only matter if people can actually access them, without fear, shame or coercion. Ending this epidemic means creating environments where people are safe to make informed choices about their own health. The fight to end the HIV epidemic is not just about what happens in labs — it's about how we make these innovations real for our communities. Science is doing its part. Now is the time to urge Congress to reject any cuts to CDC HIV prevention efforts and to fully fund the HIV response. We have the tools to end this epidemic, but not if we dismantle the very systems our communities rely on to survive. The promise of lenacapavir, and the hope it represents, is too great to let fall through the cracks of policy neglect. The question is, will we make the choice to ensure that this breakthrough reaches all of us? Science has given us the tools. Now, we must ensure that everyone has the opportunity to use them.


UPI
8 hours ago
- UPI
At least 67 Gazans killed waiting for aid, death toll rises
1 of 2 | Wounded Palestinians, including children, were transported to the Kuwaiti field hospital after an Israeli airstrike struck the Al-Mawasi area in Khan Yunis, southern Gaza, on Thursday. At least 67 people died while awaiting UN aid Sunday. Photo by Kuwaiti Hospital Press Service/UPI | License Photo July 20 (UPI) -- At least 67 people waiting for aid from the United Nations in northern Gaza have been killed, the Hamas-run health ministry said. The U.N. World Food Program said its 25-truck convoy "encountered massive crowds of hungry civilians which came under gunfire" after it cleared checkpoints and crossed into Israel, the BBC reported. The Israel Defense Forces said it "fired warning shots" to remove what it called "an immediate threat" in the area, and disrupted the number of casualties, and added that it is investigating the incident. The Palestinian Red Crescent claimed that Israeli military forces "targeted civilians waiting for humanitarian aid" north of Beit Lahia. The health ministry reported Saturday that extreme hunger was growing in the region and an increasing number of people were arriving at the aid site "in a state of extreme exhaustion and fatigue." "We warn that hundreds of people whose bodies have wasted away are at risk of imminent danger due to hunger," the U.N. said. Civilians in Gaza are starving, the U.N. continued, and called for an immediate influx of essential aid. Gaza's civil defense agency said Israeli fire had killed a total of at least 94 people and wounded dozens more across Gaza on Sunday, 80 of whom it said were shot dead in northern Gaza while they were receiving flour and bread, and another 9 were killed near an aid point in Rafah. Four additional people were fatally wounded near an aid station in Khan Younis. The health ministry said at least 19 people had died due to "starvation" in what it has called one of the deadliest days of casualties in the 21-month long conflict between Israel and Hamas, the latest chapter of which dates to Oct. 7, 2023.
Yahoo
15 hours ago
- Yahoo
Tuberville says Trump health issues exacerbated by ‘fighting the radicals'
After President Trump was diagnosed with a chronic vein condition, Sen. Tommy Tuberville (R-Ala.) suggested the president's health condition could be a result of his efforts in 'fighting the radicals.' 'The pressure on somebody like President Trump right now, not just from outside entities … all over the world but also fighting the radicals in this country,' Tuberville said during a Sunday interview with radio host John Catsimatidis on WABC 770 AM's 'The Cats Roundtable. 'Every day it's almost like a fistfight.' The White House announced Thursday that Trump had been diagnosed with chronic venous insufficiency, a condition where leg veins have difficulty sending blood back to the heart. It often results in ankle swelling and is common in people over the age of 70. On the show, Tuberville repeated baseless claims that the 2020 presidential election was stolen from Trump and claimed that illegal immigrants were voting in droves for Democrats. Tuberville also bashed Zohran Mamdani, the Democratic nominee for New York City mayor. 'He's a communist! No police? Are you kidding me?' the Alabama senator exclaimed. Mamdani called for defunding the police in 2020, but vowed not to do so during a June debate. He identifies as a Democratic socialist. Catsimatidis is leading a coalition of wealthy business leaders to back Mayor Eric Adams' bid for re-election as a way to oppose Mamdani, Politico reported in June. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.